Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population

Ghasoub Rola, Hesham Elsabah, Layaly Bakir, Maria Benkhadra, Liam Fernyhough, Awni Alshurafa, Salma Mustafa, Rajvir Singh, Honar Cherif, Mohammad Bakr

Blood (2024) 144 (Supplement 1): 7719.

https://doi.org/10.1182/blood-2024-204728

Published: 2024

Journal Articles

AL Amyloidosis with Nephrotic Syndrome: Clinical Response to Treatment Only after a Long-Term Maintenance Therapy with Daratumumab

Hawra Shawayli, Honar Cherif, Dina Sameh Soliman, Deena Mudawi, Elmustafa Abdalla, Abdulrahman Al-Mashdali, Mohammed Abdulgayoom, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2024-201993

Published: 2024

Journal Articles

Early T-Precursor ALL/Lbl Profiling in Adult Population. A10-Years Single Centre Experience

Dina Sameh Soliman, Anil Yousaf, Halima El Omri, Shehab Mohamed, Susanna Akiki, Prem Chandra, Honar Cherif, Sarah Elkourashy, Feryal Abbas

Blood (2024) 144 (Supplement 1): 5850.

https://doi.org/10.1182/blood-2024-199456

Published: 2024

Journal Articles

Serious Bleeding Manifestations in Patients with Newly Diagnosed Acute Myeloid Leukemia: A Single Center Experience

Mohammed Abdulgayoom, Hawra Shawayli, Dina Sameh Soliman, Elmustafa Abdalla, Deena Mudawi, Feryal Abbas, Susanna Akiki, Yousef Al-Asa'd, Ahmed Ali, Kalpana Singh, Honar Cherif, Shehab Mohamed

Blood (2024) 144 (Supplement 1): 5976.

https://doi.org/10.1182/blood-2024-205585

Published: 2024

Journal Articles

Characteristics and Outcomes of Adolescent, Young Adults, and Adults 40-50 Years Old with Multiple Myeloma: A Single Center Experience

Shehab Mohamed, Hesham Elsabah, Hawra Shawayli, Feryal Abbas, Dina Sameh Soliman, Mohammad Afana, Deena Mudawi, Samah Ahmed Samy Kohla, Halima El Omri, Nancy Kessam, Anil Ellahie, Mohammed Abdulgayoom, Yahya Mulikandathil, Ibrahim Ganow, Awni Alshurafa, Kalpana Singh, Amna Gameil, Honar Cherif

Blood (2023) 142 (Supplement 1): 6647.

https://doi.org/10.1182/blood-2023-187816

Published: 2023

Journal Articles

Hyperleukocytosis in Patients with Acute Myeloid Leukemia Characteristics and Outcome, a Single-Center Experience

Shehab Mohamed, Hawra Shawayli, Feryal Abbas, Dina Sameh Soliman, Mohammad Afana, Mohamed A Yassin, Deena Mudawi, Hesham Elsabah, Samah Ahmed Samy Kohla, Yahya Mulikandathil, Aliaa Amer, Awni Alshurafa Alshurafa, Kalpana Singh, Halima El Omri, Amna Gameil, Honar Cherif

Blood (2023) 142 (Supplement 1): 5836.

https://doi.org/10.1182/blood-2023-185817

Published: 2023

Journal Articles

Deep Learning Models for the Diagnosis of Acute Lymphoblastic Leukemia from Bone Marrow Images : A Comprehensive Literature Review

Basel Elsayed, Amgad Elshoeibi, Mohamed Elhadary, Ahmed Badr, Omar Metwalli, Honar Cherif, Deena Mudawi, Awni Alshurafa, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 7184.

https://doi.org/10.1182/blood-2023-187037

Published: 2023

Journal Articles

Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State of the Art and Future Prospects

Amgad Elshoeibi, Ahmed Badr, Basel Elsayed, Omar Metwalli, Mohamed Elhadary, Ahmad Alhuraiji, Honar Cherif, Fatima Khadadah, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 7183.

https://doi.org/10.1182/blood-2023-186275

Published: 2023

Journal Articles

Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region

Fatima Khadadah, Honar Cherif, Halima El Omri, Ahmed Absi, Noor Merwass, Mohamed I. Abu Haleeqa, Waed Jaber, Ahmad Alhuraiji, Ramesh Pandita

Blood (2023) 142 (Supplement 1): 7428.

https://doi.org/10.1182/blood-2023-181520

Published: 2023

Journal Articles

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Rola Ghasoub, Shereen Elazzazy, Maria Benkhadra, Nancy Kassem, Honar Cherif, Javid Gaziev, Hesham Elsabah, Anas Ahmad Hamad

Blood (2023) 142 (Supplement 1): 5079.

https://doi.org/10.1182/blood-2023-185615

Published: 2023

Journal Articles

Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study

Shehab Fareed Mohamed, Yahya Mulikandathil, Dina Sameh Soliman, Feryal Abbas, Awni Alshurafa, Mohammad Afana, Anil Yousaf Ellahie, Deena Sideeg Mudawi, Halima El Omri, Amna Gameil, Tareq Abuasab, Fadi Haddad, Kalpana Singh, Nancy Kassem, Honar Cherif

Blood (2022) 140 (Supplement 1): 11651–11652.

https://doi.org/10.1182/blood-2022-167176

Published: 2022

Journal Articles

A Comparative Study between Acute Myeloid Leukemia in Adolescent and Young Adults (AYA) Versus Non-AYA Patients: Single Center Experience

Shehab Fareed Mohamed, Awni Alshurafa, Dina Sameh Soliman, Halima El Omri, Deena Sideeg Mudawi, Mohamed A Yassin, Mohammad Afana, Hesham Elsabah, Anil Yousaf Ellahie, Nancy Kassem, Tareq Abuasab, Fadi Haddad, Samah Kohla, Aliaa Amer, Kalpana Singh, Honar Cherif

Blood (2022) 140 (Supplement 1): 11646–11648.

https://doi.org/10.1182/blood-2022-165462

Published: 2022

Journal Articles

Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML): A Single Center Experience

Shehab Fareed Mohamed, Mohammad Afana, Dina Sameh Soliman, Feryal Abbas, Halima El Omri, Tareq Abuasab, Fadi Haddad, Mohamed A Yassin, Deena Sideeg Mudawi, Hesham Elsabah, Samah Kohla, Aliaa Amer, Yahya Mulikandathil, Amna Gameil, Awni Alshurafa, Kalpana Singh, Honar Cherif

Blood (2022) 140 (Supplement 1): 11661–11662.

https://doi.org/10.1182/blood-2022-163341

Published: 2022

Journal Articles

Sickle Cell Disease in Sweden - Prevalence and Resource Use Estimated through Population-Based National Registers

Christian Kjellander, Emma Hernlund, Moa Ivergård, Axel Svedbom, Therese Dibbern, Anna Stenling, Fredrik Sjöö, Simona Vertuani, Andreas Glenthøj, Honar Cherif

Blood (2021) 138 (Supplement 1): 2040.

https://doi.org/10.1182/blood-2021-147336

Published: 2021

Journal Articles

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Michael Dickinson, Honar Cherif, Pierre Fenaux, Moshe Mittelman, Amit Verma, Maria Socorro O. Portella, Paul Burgess, Pedro Marques Ramos, Jeea Choi, Uwe Platzbecker

Blood (2018) 132 (25): 2629–2638.

https://doi.org/10.1182/blood-2018-06-855221

Published: 2018

Includes: Supplemental data

Journal Articles

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Honar Cherif, MD, PhD, Martin Hoglund, MD, PhD, Karlis Pauksens, MD PhD

Blood (2012) 120 (21): 1054.

https://doi.org/10.1182/blood.V120.21.1054.1054

Published: 2012

Journal Articles

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Christian Karl Kjellander, MD, Honar Cherif, MD, PhD, Magnus Björkholm, MD, PhD, Mats Kalin, Md, PhD, Christian G Giske, MD, PhD

Blood (2010) 116 (21): 4868.

https://doi.org/10.1182/blood.V116.21.4868.4868

Published: 2010

Journal Articles

Outcome and Early Prognostic Indicators in Patients with Hematological Disorders Admitted to the Intensive Care Unit for a Life-Threatening Complication.

Honar Cherif, MD, Jan Hansen, MD, Mats Kalin, Magnus Bjorkholm Prof

Blood (2005) 106 (11): 1329.

https://doi.org/10.1182/blood.V106.11.1329.1329

Published: 2005

Journal Articles

Antibody Response to Pneumococcal Polysaccharide Vaccination Predicts Pneumococcal Disease in Splenectomized Patients with Hematological Diseases.

Honar Cherif, MD, Magnus Bjorkholm, Mats Kalin, Helle B. Konradsen, MD, Ola Landgren, MD PHD

Blood (2004) 104 (11): 1335.

https://doi.org/10.1182/blood.V104.11.1335.1335

Published: 2004

NARROW

A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population

AL Amyloidosis with Nephrotic Syndrome: Clinical Response to Treatment Only after a Long-Term Maintenance Therapy with Daratumumab

Early T-Precursor ALL/Lbl Profiling in Adult Population. A10-Years Single Centre Experience

Serious Bleeding Manifestations in Patients with Newly Diagnosed Acute Myeloid Leukemia: A Single Center Experience

Characteristics and Outcomes of Adolescent, Young Adults, and Adults 40-50 Years Old with Multiple Myeloma: A Single Center Experience

Hyperleukocytosis in Patients with Acute Myeloid Leukemia Characteristics and Outcome, a Single-Center Experience

Deep Learning Models for the Diagnosis of Acute Lymphoblastic Leukemia from Bone Marrow Images : A Comprehensive Literature Review

Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State of the Art and Future Prospects

Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study

A Comparative Study between Acute Myeloid Leukemia in Adolescent and Young Adults (AYA) Versus Non-AYA Patients: Single Center Experience

Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Acute Myeloid Leukemia (AML): A Single Center Experience

Sickle Cell Disease in Sweden - Prevalence and Resource Use Estimated through Population-Based National Registers

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Outcome and Early Prognostic Indicators in Patients with Hematological Disorders Admitted to the Intensive Care Unit for a Life-Threatening Complication.

Antibody Response to Pneumococcal Polysaccharide Vaccination Predicts Pneumococcal Disease in Splenectomized Patients with Hematological Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only